The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2016
DOI: 10.21037/jtd.2016.12.80
|View full text |Cite
|
Sign up to set email alerts
|

Randomized trial of thymectomy in myasthenia gravis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
166
3
3

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 122 publications
(185 citation statements)
references
References 11 publications
4
166
3
3
Order By: Relevance
“…We appreciate the wide interest in the results from the international extended transsternal thymectomy trial in non-thymomatous myasthenia gravis (MG) (1). Correspondence has been received from several medical communities including neurologists, thoracic surgeons, and pathologists.…”
Section: To the Editormentioning
confidence: 99%
“…We appreciate the wide interest in the results from the international extended transsternal thymectomy trial in non-thymomatous myasthenia gravis (MG) (1). Correspondence has been received from several medical communities including neurologists, thoracic surgeons, and pathologists.…”
Section: To the Editormentioning
confidence: 99%
“…This indication was recently confirmed in a randomized clinical trial comparing extended transsternal thymectomy and standard clinical treatment; better outcomes were observed in 3-year followup in the surgical group (2). Similarly, to what happened with thymic malignancies, many surgeons had the perception that MIS for thymectomy in myasthenic patients would result in an incomplete procedure.…”
Section: Introductionmentioning
confidence: 83%
“…It has been reported that remission and recovery rates of MG in patients with thymoma are similar or slightly worse than those without thymoma [10]. Non-thymomatous MG (anti-AChR antibody-positive) In the absence of thymoma, thymectomy is generally thought to be beneficial to generalize MG and AChR antibodies-positive patients [11][12][13]. Appropriate age for surgery, stage in which surgery will be performed during the course of the disease, surgery approach type, role of thymectomy in ocular MG, seronegative MG, and MuSK antibodies-associated MG cases are still questions to be answered.…”
Section: Thymomatous Mgmentioning
confidence: 99%
“…In 2016, Wolfe et al [13] (MGTX Study Group) report the results of a randomized, controlled trial comparing the effects of thymectomy and prednisone therapy versus prednisone therapy alone. The results supported the benefit of thymectomy in patients with non-thymomatous MG.…”
Section: Efficiency Of Thymectomymentioning
confidence: 99%